Ignite Creation Date:
2024-05-06 @ 3:33 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04672434
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-02
First Post:
2020-12-07
Brief Title:
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Sponsor:
Symphogen AS
Organization:
Symphogen AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
| Metastatic Cancer |
Keywords:
| Name | View |
|---|---|
| Locally advancedunresectable | View |
| Metastatic solid tumor | View |
| Anti-PD-1 | View |
| PD-1 | View |
| PD1 | View |
| CD73 | View |
| Squamous cell carcinoma of the head and neck SCCHN | View |
| Non-small-cell lung carcinoma-adenocarcinoma histology subtype NSCLC-Adeno | View |
| Pancreatic ductal adenocarcinoma PDAC | View |
| Cholangiocarcinoma CCA | View |
| Colorectal carcinoma CRC | View |
| Gastric carcinoma GC | View |
| Esophageal carcinoma EsoCA | View |
| Mesothelioma Meso | View |
| Sym021 | View |
| Sym024 | View |
| Head and neck squamous cell carcinoma HNSCC | View |
| Cervical carcinoma CC | View |